Literature DB >> 3114327

Abnormal intestinal permeability and jejunal morphometry.

L D Juby, M F Dixon, A T Axon.   

Abstract

The cellobiose and mannitol differential sugar test is a non-invasive investigation of small bowel permeability, in which urinary recoveries of cellobiose and mannitol after a hyperosmolar oral load are expressed as a ratio to give a permeability index. Changes in the cellobiose:mannitol ratio often occur in coeliac disease, but some patients with abnormal permeability have normal jejunums by routine microscopy. Using computed morphometry the perimeter:lamina propria area index of jejunal biopsy samples was measured and compared with the cellobiose:mannitol ratio in three groups of patients: (i) those with coeliac disease with villous atrophy; (ii) those with normal jejunums and sugar test results: and (iii) those with normal jejunums but abnormal sugar test results. In addition to the expected difference in perimeter:lamina propria area index between patients with coeliac disease and those with normal findings (p less than 0.001), the index was also abnormal in patients with normal jejunums but abnormal sugar test results: (p less than 0.001 compared with group 1) and (0.01 greater than p greater than 0.001 compared with group 2). There was a significant overall correlation between the perimeter:lamina propria area index and cellobiose:mannitol ratio (p = 0.001). This study shows that computed jejunal morphometry can identify patients with subtle morphological changes that are related to abnormal intestinal permeability.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114327      PMCID: PMC1141086          DOI: 10.1136/jcp.40.7.714

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Non-invasive test for small-intestinal mucosal damage.

Authors:  I Cobden; J Rothwell; A T Axon
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

2.  Does screening by "Pap" smears help prevent cervical cancer? A case-control study.

Authors:  E A Clarke; T W Anderson
Journal:  Lancet       Date:  1979-07-07       Impact factor: 79.321

3.  Gastrointestinal permeability in food-allergic eczematous children.

Authors:  G C Du Mont; R C Beach; I S Menzies
Journal:  Clin Allergy       Date:  1984-01

4.  Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge.

Authors:  I Hamilton; I Cobden; J Rothwell; A T Axon
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

5.  Intestinal permeability in patients with eczema and food allergy.

Authors:  P G Jackson; M H Lessof; R W Baker; J Ferrett; D M MacDonald
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

6.  Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum.

Authors:  S Strobel; W G Brydon; A Ferguson
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

7.  Prenatal diagnosis of congenital rubella.

Authors:  F Daffos; F Forestier; L Grangeot-Keros; M Capella Pavlovsky; P Lebon; M Chartier; J Pillot
Journal:  Lancet       Date:  1984-07-07       Impact factor: 79.321

8.  Quantitative analysis of small intestinal mucosa in cow's milk-sensitive enteropathy.

Authors:  C Maluenda; A D Phillips; A Briddon; J A Walker-Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-06       Impact factor: 2.839

9.  Intestinal permeability in children with Crohn's disease and coeliac disease.

Authors:  A D Pearson; E J Eastham; M F Laker; A W Craft; R Nelson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

10.  Intestinal permeability and screening tests for coeliac disease.

Authors:  I Cobden; J Rothwell; A T Axon
Journal:  Gut       Date:  1980-06       Impact factor: 23.059

View more
  9 in total

1.  Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs.

Authors:  E J Hall; R M Batt
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

2.  Citrulline as a Biomarker for Gastrointestinal-Acute Radiation Syndrome: Species Differences and Experimental Condition Effects.

Authors:  K Bujold; M Hauer-Jensen; O Donini; A Rumage; D Hartman; H P Hendrickson; J Stamatopoulos; H Naraghi; M Pouliot; A Ascah; M Sebastian; M K Pugsley; K Wong; S Authier
Journal:  Radiat Res       Date:  2016-06-28       Impact factor: 2.841

3.  Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial.

Authors:  Jaya Benjamin; Govind Makharia; Vineet Ahuja; K D Anand Rajan; Mani Kalaivani; Siddhartha Datta Gupta; Yogendra Kumar Joshi
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

4.  Small intestinal permeability to mannitol and lactulose in the three ethnic groups resident in west Birmingham.

Authors:  T H Iqbal; K O Lewis; J C Gearty; B T Cooper
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

5.  Mucosal protective effects of vitamin E and misoprostol during acute radiation-induced enteritis in rats.

Authors:  L R Empey; J D Papp; L D Jewell; R N Fedorak
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

6.  Cellobiose/mannitol sugar test--a sensitive tubeless test for coeliac disease: results on 1010 unselected patients.

Authors:  L D Juby; J Rothwell; A T Axon
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

Review 7.  Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline.

Authors:  Ludy Lutgens; Philippe Lambin
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

8.  Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study.

Authors:  C Catassi; M Rossini; I M Rätsch; I Bearzi; A Santinelli; R Castagnani; E Pisani; G V Coppa; P L Giorgi
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

9.  Intestinal permeability and antigliadin antibody test for monitoring adult patients with celiac disease.

Authors:  Eduardo Garcia Vilela; Maria de Lourdes de Abreu Ferrari; Henrique Osvaldo de Gama Torres; Fabiana Paiva Martins; Eugênio Marcos Andrade Goulart; Agnaldo Soares Lima; Aloíso Sales da Cunha
Journal:  Dig Dis Sci       Date:  2007-03-14       Impact factor: 3.487

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.